Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma

Journal of Carcinogenesis

Volumn 10, Issue , 2011, Pages

  Jacobs, Elizabeth ^a   Martinez, Maria Elena ^a   Buckmeier, Julie ^a   Lance, Peter ^a   May, Melissa ^a   Jurutka, Peter ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Adenoma; cancer; colorectal; fibroblast growth factor; fibroblast growth factor 23

Indexed keywords

25 HYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; FIBROBLAST GROWTH FACTOR 23;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RISK; COLORECTAL ADENOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METACHRONOUS COLORECTAL ADENOMA; PROSPECTIVE STUDY;

EID: 79960338678     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.76723     Document Type: Article

References (17)

1. Marsell R, Jonsson KB. The phosphate regulating hormone fibroblast growth factor-23. Acta Physiol (Oxf). 2010; 200:97-106.
2. Haussler MR, Haussler CA, Whitfield GK, Hsieh JC, Thompson PD, Barthel TK, et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J Steroid Biochem Mol Biol 2010;121:88-97.
3. Jurutka PW, Bartik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, et al. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Miner Res 2007;22:V2-10.
4. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13:325-49. (Pubitemid 28146215)
5. Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 1993;53:3712-8. (Pubitemid 23252030)
6. Giovannucci E. Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res 2007;22:V81-5. (Pubitemid 351304655)
7. Tebben PJ, Kalli KR, Cliby WA, Hartmann LC, Grande JP, Singh RJ, et al. Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clin Proc 2005;80:745-51. (Pubitemid 40770361)
8. Alberts DS, Martnez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, et al. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 2005;97:846-53. (Pubitemid 40909127)
9. Hollis BW. Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin Chem 1986;32:2960-3.
10. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993;39:529-33. (Pubitemid 23099026)
11. Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, et al. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res 1996;56:3570-6. (Pubitemid 26251654)
12. Plmer HG, Gonzlez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001;154:369-87. (Pubitemid 34286147)
13. Wong NA, Pignatelli M. Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 2002;160:389-401.
14. Egan JB, Thompson PA, Vitanov MV, Bartik L, Jacobs ET, Haussler MR, et al. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells. Mol Carcinog 2010;49:337-52.
15. Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007;18:1637-47. (Pubitemid 46870300)
16. Jang JH. Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis. Oncogene 2005;24:945-8.
17. Marsell R, Mirza MA, Mallmin H, Karlsson M, Mellstrm D, Orwoll E, et al. Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men. Osteoporos Int 2009;20:1167-73.